SCHEMBL1664758

SCHEMBL1664758

O=C(Nc1ccc(C(=O)c2ccc(Nc3ccc(N4CCC(O)CC4)cc3)cc2)cc1)c1cn[nH]c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.46
RAB9A P51151 9/20 0.46
NPC1 O15118 8/20 0.46
SMN1; SMN2 Q16637 5/20 0.46
GAA P10253 1/20 0.46
SYK P43405 1/20 0.43
KMT2A Q03164 5/20 0.43
ALDH1A1 P00352 3/20 0.43
MCL1 Q07820 2/20 0.43
MEN1 O00255 2/20 0.43
LMNA P02545 2/20 0.43
NR4A1 P22736 1/20 0.43
USP2 O75604 2/20 0.43
KDM4E B2RXH2 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TNIK Q9UKE5 1/20 0.42
HPGDS O60760 1/20 0.42
TP53 P04637 4/20 0.42
ALOX15 P16050 2/20 0.42
MAPK1 P28482 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1664752 0.96 MAPT (0.47) MAPTRAB9ANPC1SMN1; SMN2GAA
SCHEMBL1664760 0.96 MAPT (0.47) MAPTRAB9ANPC1SMN1; SMN2GAA
SCHEMBL1664750 0.96 MAPT (0.49) MAPTRAB9ANPC1SMN1; SMN2GAA
SCHEMBL1663802 0.87 HDAC8 (0.58) MAPTRAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL1664358 0.85 NPC1 (0.46) MAPTRAB9ANPC1SMN1; SMN2GAA
SCHEMBL1664469 0.84 RAB9A (0.58) MAPTRAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL8769706 0.84 RAB9A (0.58) MAPTRAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL1663807 0.82 HDAC8 (0.64) MAPTRAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL1664289 0.82 NPC1 (0.47) MAPTRAB9ANPC1SMN1; SMN2GAA
SCHEMBL1663789 0.82 NPC1 (0.51) MAPTRAB9ANPC1SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642994-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS Ligand Pharmaceuticals Incorporated (US) 2013-10-02 EP disclosed
EP-2488486-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES Ligand Pharmaceuticals Inc. (US) 2012-08-22 EP disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed